Derivatives of aryl(or heteroaryl) azolylcarbinols for the treatement ofurinary incontinence
CA 2452646 A1 · Owner: Laboratorios Del Dr. Esteve S.A. · Inventors: Andaluz-Mataro, Blas; Merce-Vidal, Ramon; Frigola-Constansa, Jordi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to aryl (or heteroaryl) azolylcarbynol derivatives having general formula (I), wherein: Ar represents an optionally substituted phenyl radical or thienyl radical; R1191 represents a hydrogen atom or a lower alkyl group; R2191 represents a dialkylaminoalkyl or azaheterocycloalkyl radical; and Het represents a non-substituted azole or an azole optionally substituted by one or two substituents. The invention also relates to the physiologically-acceptable salts of said derivatives. The inventive derivatives can be used as medicaments in human and/or veterinary therapy for the treatment of urinary incontinence in mammals including humans.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 1, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended July 1, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 1, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.